diclofenac has been researched along with pep005 in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 21 (87.50) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, AK; Paquet, M | 1 |
| Calzavara Pinton, P; Catricalà, C; Neri, L; Pellacani, G; Peris, K; Peserico, A; Pimpinelli, N | 1 |
| Kemmett, D; Nasr, R; Smethurst, H; Thybo, S; Tolley, K | 1 |
| Isoherranen, K; Koskenmies, S; Overmark, M; Pitkänen, S; Saksela, O; Ylitalo, L | 1 |
| Erdmann, R; Jacobs, A; Nast, A; Rosumeck, S; Sporbeck, B; Werner, RN | 1 |
| Bottoni, U; Del Duca, E; Gliozzi, M; Muscoli, C; Nisticò, S; Torchia, V | 1 |
| Gilaberte, Y; González, S; Gracia-Cazaña, T | 1 |
| Athanasakis, K; Boubouchairopoulou, N; Kontodimas, S; Kyriopoulos, J; Tarantilis, F; Tsiantou, V | 1 |
| Holmstrup, H; Jemec, GBE; Malmberg, I; Norlin, JM; Norrlid, H; Ragnarson Tennvall, G; Sartorius, K; Thormann, H | 1 |
| Borkowska, JK; Czuwara, J; Damps, T; Konop, M; Kowalkowski, T; Laskowska, AK; Misicka, A; Prokopowicz, M; Puszko, AK; Różycki, K; Rudnicka, L; Sosnowski, P | 1 |
| Harwood, CA; Larsson, T; Serra-Guillén, C; Skov, T; Stockfleth, E; Østerdal, ML | 2 |
| Malvehy, J; Puig, S | 1 |
| Bagatin, E | 1 |
| da Motta, VRV; de Oliveira, ECV; Galadari, H; Ilha, CSO; Leonardi, GR; Magalhães, RF; Pantoja, PC | 1 |
| Bastian, M; Stockfleth, E | 1 |
| Almazan-Fernandez, FM; Husein-ElAhmed, H; Husein-ElAhmed, S | 1 |
| Calzavara-Pinton, P; Hamon, P; Tanova, N | 1 |
| Council, ML; Nemer, KM | 1 |
| Herms, F | 1 |
| Collins, A; Doerfler, L; Savas, J | 1 |
| Bastian, M; Hansen, JB; Larsson, T; Schmitz, L; Stockfleth, E | 1 |
| Arisi, M; Calzavara-Pinton, I; Calzavara-Pinton, PG; Caravello, S; Cozzi, C; Moggio, E; Polonioli, M; Rossi, MT; Soglia, S; Tomasi, C; Venturini, M; Zane, C | 1 |
| Baker, C; MacMahon, B; Sinclair, R; Spelman, L; Supranowicz, M | 1 |
8 review(s) available for diclofenac and pep005
| Article | Year |
|---|---|
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cryotherapy; Diclofenac; Diterpenes; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Hyaluronic Acid; Imiquimod; Immunocompetence; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
[Diagnosis and treatment of actinic keratosis].
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cryotherapy; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Precancerous Conditions; Primary Health Care | 2015 |
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Presenting Cells; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Dermatologic Agents; Diclofenac; Diterpenes; Drug Resistance, Neoplasm; Fluorouracil; Humans; Imiquimod; Meta-Analysis as Topic; Neoplasm Proteins; Neoplastic Stem Cells; Skin Neoplasms | 2016 |
Actinic keratosis - review for clinical practice.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cryotherapy; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Retinoids | 2019 |
Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
Topics: Administration, Cutaneous; Animals; Apoptosis; Dermatologic Agents; Diclofenac; Diterpenes; Humans; Hyaluronic Acid; Keratosis, Actinic; Medication Adherence; Ultraviolet Rays | 2018 |
Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Niacinamide; Photochemotherapy; Retinoids; Skin Neoplasms | 2019 |
Nonsurgical Treatments for Nonmelanoma Skin Cancer.
Topics: Administration, Cutaneous; Anilides; Antineoplastic Agents; Antineoplastic Agents, Immunological; Biphenyl Compounds; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Programmed Cell Death 1 Receptor; Pyridines; Radiotherapy; Skin Neoplasms; Watchful Waiting | 2019 |
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.
Topics: Antineoplastic Agents; Diclofenac; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Recurrence; Skin Neoplasms | 2021 |
3 trial(s) available for diclofenac and pep005
| Article | Year |
|---|---|
Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Dermatologic Agents; Diclofenac; Diterpenes; Drug Administration Schedule; Facial Dermatoses; Female; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Scalp Dermatoses; Treatment Outcome | 2018 |
Treatment responder analysis in actinic keratosis: can it lead the way to individualized choice of treatment?
Topics: Aged; Diclofenac; Diterpenes; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Treatment Outcome | 2021 |
Effects of MAL-PDT, ingenol mebutate and diclofenac plus hyaluronate gel monitored by high-frequency ultrasound and digital dermoscopy in actinic keratosis - a randomized trial.
Topics: Aminolevulinic Acid; Dermoscopy; Diclofenac; Diterpenes; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2020 |
13 other study(ies) available for diclofenac and pep005
| Article | Year |
|---|---|
Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop.
Topics: Aminoquinolines; Carcinoma, Squamous Cell; Case Management; Clinical Trials as Topic; Cryosurgery; Diagnosis, Differential; Diclofenac; Disease Management; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Radiation-Induced; Photochemotherapy; Practice Guidelines as Topic; Skin Neoplasms; Sunscreening Agents; United Kingdom; United States; Watchful Waiting | 2013 |
A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
Topics: Cost-Benefit Analysis; Cryotherapy; Diclofenac; Diterpenes; Dose-Response Relationship, Drug; Fluorouracil; Humans; Keratolytic Agents; Keratosis, Actinic; Models, Econometric; Quality-Adjusted Life Years; Recurrence; Salicylic Acid; Scotland; Treatment Outcome | 2016 |
Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.
Topics: Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Cryotherapy; Curettage; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Evidence-Based Medicine; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Lasers, Gas; Photochemotherapy | 2015 |
Pharmacoeconomy of drugs used in the treatment of actinic keratoses.
Topics: Cost-Benefit Analysis; Diclofenac; Diterpenes; Humans; Italy; Keratosis, Actinic; Quality of Life; Treatment Outcome | 2016 |
Cost-effectiveness of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis in Greece.
Topics: Aminoquinolines; Cost-Benefit Analysis; Diclofenac; Diterpenes; Greece; Humans; Imiquimod; Keratosis, Actinic; Quality-Adjusted Life Years | 2017 |
Patient-reported outcomes in topical field treatment of actinic keratosis in Swedish and Danish patients.
Topics: Administration, Topical; Aged; Aminoquinolines; Denmark; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Quality of Life; Surveys and Questionnaires; Sweden | 2018 |
The effect of wool hydrolysates on squamous cell carcinoma cells in vitro. Possible implications for cancer treatment.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Diclofenac; Diterpenes; Fluorouracil; Humans; Keratinocytes; Protein Hydrolysates; Skin Neoplasms; Wool | 2017 |
Response to 'Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp'.
Topics: Diclofenac; Diterpenes; Humans; Keratosis, Actinic; Scalp | 2018 |
Response to 'Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp': reply from the authors.
Topics: Diclofenac; Diterpenes; Humans; Keratosis, Actinic; Scalp | 2018 |
Treating actinic keratosis: assessment of effectiveness, discomfort, costs and follow-up.
Topics: Diclofenac; Diterpenes; Follow-Up Studies; Humans; Keratosis, Actinic; Scalp | 2018 |
Ingenol mebutate versus imiquimod versus diclofenac for actinic cheilitis: a 6-month follow-up clinical study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cheilitis; Diclofenac; Diterpenes; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged | 2019 |
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Fluorouracil; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cost-Benefit Analysis; Cryotherapy; Dermatologic Agents; Diclofenac; Diterpenes; Electrocoagulation; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy | 2019 |